Dr. Farless, a board-certified orthopedic surgeon, currently practices at the Cleburne (Texas) Orthopedic and Sports Medicine and is also a staff surgeon at the Texas Health Harris Methodist Hospital Cleburne and the Glen Rose (Texas) Medical Center.
“Bone bleeding during surgery has always been an issue and although bee’s wax was adequate and easy to use, it prevented bone healing and created potential problems down the road,” said Dr. Farless. “Next generation products did not cause long term problems but were difficult to use in addition to being less effective and more costly. The resorbable hemostat products in development by the ROP subsidiary of Wound Management Technologies appears to offer ease of use and cost effectiveness in addition to not slowing bone growth and avoiding long term problems. I am thrilled at the opportunity to work with the company as we bring this product to market.”
More articles on devices:
Smith & Nephew launches long bone fracture plating system — 5 things to know
Spine Wave launches lateral access product portfolio
Live webcast to feature S&N’s total knee system, cutting guides
